Tuesday, January 6, 2015

CytomX Finds $20M More

South San Francisco-based biotech CytomX said this morning that it has raised $20M more, in a Series C funding round. The round was led by Pfizer Venture Investments, and also included Third Rock Ventures, Canaan Partners and the Roche Venture Fund. CytomX is developing therapeutics aimed at treating cancer tumors, and is led by Sean McCarthy. More information »